-
Feb 09, 2021 11:48 PM IST Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 31, 2021.
-
Feb 08, 2021 04:07 PM IST Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 950 in its research report dated January 29, 2021.
-
Feb 04, 2021 06:51 PM IST Prabhudas Lilladher recommended accumulate rating on Cipla with a target price of Rs 913 in its research report dated February 01, 2021.
-
Feb 04, 2021 05:23 PM IST ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 975 in its research report dated January 30, 2021.
-
Feb 03, 2021 09:57 AM IST New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin
-
Feb 02, 2021 09:07 PM IST Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 900 in its research report dated January 30, 2021.
-
Feb 02, 2021 02:33 PM IST HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 01, 2021.
-
Feb 02, 2021 09:44 AM IST -
Feb 02, 2021 09:11 AM IST -
Feb 01, 2021 07:32 PM IST Focus on creating health infrastructure in the Budget 2021 is clearly an incrementally structural move which should indirectly benefit all the domestic oriented companies
-
Jan 31, 2021 12:48 PM IST In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity
-
Jan 29, 2021 05:07 PM IST The company's revenue for the quarter came at Rs 5,168.7 crore, up 18.2 percent from Rs 4,371 crore in the year-ago quarter.
-
Jan 22, 2021 12:59 PM IST Net Sales are expected to increase by 14 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 4985 crore, according to Yash Securities.
-
Jan 18, 2021 10:57 PM IST Net Sales are expected to increase by 15.3 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 4,234.6 crore, according to Prabhudas Lilladher.
-
Jan 18, 2021 08:08 PM IST Net Sales are expected to increase by 15.7 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 5,057.6 crore, according to ICICI Direct.
-
Dec 31, 2020 02:15 PM IST The pharmaceutical sector is expecting sales to normalise by the second half of 2021, with the availability of COVID-19 vaccine and coronavirus receding.
-
Dec 22, 2020 12:58 PM IST According to ICICI Direct, Buy Cipla in range of Rs 790-807 Target: Rs 930 Stop Loss: Rs 725 Time frame: Three months.
-
Dec 16, 2020 09:36 AM IST The company will commence the supply of rapid antigen test kits for COVID-19 in India from this week.
-
Dec 14, 2020 01:39 PM IST HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 940 in its research report dated December 14, 2020.
-
Dec 14, 2020 01:37 PM IST Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 887 in its research report dated December 14, 2020.
-
Dec 14, 2020 09:39 AM IST Nomura has maintained buy rating with a target at Rs 861 per share.
-
Nov 12, 2020 04:01 PM IST Prabhudas Lilladher recommended Hold rating on Cipla with a target price of Rs 836 in its research report dated November 09, 2020.
-
Nov 11, 2020 11:29 AM IST Sharekhan is bullish on Cipla recommended buy rating on the stock with a target price of Rs 950 in its research report dated November 06, 2020.
-
Nov 09, 2020 02:51 PM IST Remdesivir was developed by US drugmaker Gilead Sciences Inc , which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.
-
Nov 09, 2020 01:38 PM IST Dolat Capital Market is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 942 in its research report dated November 07, 2020.